Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsCapital Bluecross formulary coverage & Prior Auth …
    Ask Trek AI about this page
    CurrentCapital BluecrossPolicy N/A

    2026 Exclusive Full DRUG LIST (Formulary)

    Customize your policy alerts

    Sign up for all Capital Bluecross policy alerts

    Know when Capital Bluecross releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Capital Blue Cross Exclusive Full Formulary listing covered prescription drugs, tier placement, specialty designation, and utilization management indicators (prior authorization, step therapy, quantity limits, limited distribution) for fully insured individual and employer group plans in Pennsylvania.

    Policy Summary
    PayerCapital Bluecross
    Policy2026 Exclusive Full DRUG LIST (Formulary)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionIf a drug's Prior Authorization column shows an indicator (dot), the provider must submit a prior authorization request for coverage approval before the drug will be covered.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes noted in this brief (has_material_change=false).

    multipleTherapeutic classes
    ~150+Drug entries (approx.)
    multiplePA flagged items
    multiple

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Limited Distribution items
    70+Vaccine entries

    Coverage Summary

    General Formulary Coverage Criteria

    This fragment of the Capital Blue Cross 2026 Exclusive Full Drug List (Formulary) summarizes the formulary coverage stance and scope for the plan. It describes what the formulary covers and the plan-level boundaries for covered prescription drugs.

    Covered when ALL of the following are met:
    AND
    The drug is a prescription medication that is FDA‑approved (NDA, ANDA, or BLA) OR coverage is required by law or specific group benefit (for example, PPACA preventive drugs).
    AND
    The drug is included on the Capital Blue Cross Exclusive Full Formulary or a nonformulary exception is approved.
    AND
    For specialty agents, distribution is via the plan's designated specialty pharmacy (Accredo) and any limited distribution restrictions are satisfied.
    AND
    Utilization management requirements (prior authorization, step therapy, quantity limits) are met when applicable.
    OR (coverage exceptions):
    Medically necessary nonformulary drugs may be covered if an approved nonformulary exception is granted by the plan following submission by the provider.
    Leaf nodes (operational notes):
    Prior Authorization: Some drugs require provider submission and plan approval before coverage; noted in the formulary with a dot in the PA column where commonly required.
    Step Therapy: Some drugs require trials of specified alternatives before coverage of the requested drug is approved.
    Limited Distribution: If a drug is identified as limited distribution, the member may be required to obtain it from specific pharmacies designated by the manufacturer or plan (members/providers may need to contact Accredo or member services).
    Quantity/Duration Limits: Coverage may be subject to limits on days supply or quantity (eg, specialty drugs limited to 30‑day supply).

    Applicable Codes / Formulary Code Groups

    Provider Actions & Administrative Requirements

    Note
    Note
    Note
    Note
    Note
    Note
    Note

    Formulary Criteria (Operational Notes)

    Quantity / Threshold Notes

    Revision History

    Policy Summary
    PayerCapital Bluecross
    Policy2026 Exclusive Full DRUG LIST (Formulary)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionIf a drug's Prior Authorization column shows an indicator (dot), the provider must submit a prior authorization request for coverage approval before the drug will be covered.
    SourceLink
    On This Page
    Coverage SummaryApplicable Codes / Formulary Code GroupsProvider Actions & Administrative RequirementsFormulary Criteria (Operational Notes)Unproven / Not CoveredClinical Evidence & NotesBackgroundQuantity / Threshold NotesRevision History